OHRP’s Compliance Oversight Procedures

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

What FDA Looks for When Inspecting IRBs and Sponsors Marian J. Serge Nurse Consultant Division of Bioresearch Monitoring Office of Compliance Center for.
1 IRB Inspections Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago,
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Institutional Review Boards (IRBs), Informed Consent, and Responsibilities Requirement for IRBs -DHHS: 45 CFR Part 46 -FDA: 21 CFR 56 Requirement for and.
Research Involving Humans! OHRP- Office For Human Subject Protections
Sherry Davis, Manager Pacific Northwest National Laboratory Human Research Protection Program AAHRPP As A Self-Assessment Tool May, 2008.
Institutional Review Board Guidance.  Independent Ethics Committee  Ethical Review Board  Research Ethics Committee 2.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
OHRP Electronic Access Web Site:
Human Subjects Protection: Creation and Maintenance of an IRB Regulatory Requirements & Recommendations 45 CFR part 46 Freda E. Yoder Office for Human.
University of Indianapolis Institutional Review Board Protecting Study Volunteers in Research.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
IRB-Investigator/ Research Coordinator Mtg. “What You Can Do to Facilitate an Efficient IRB Review” January 13, 2004 George Gasparis.
HRPP Policies & Forms Created/Revised for AAHRPP.
Overview of Good Clinical Practices (GCPs)
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Federalwide Assurance Presentation for IRB Members.
Cornell Evaluation Network The Use of Human Participants in Research Office of Research Integrity and Assurance ~ May 14, 2007.
Response to FDA Audit 483 MX-4501N : Nine Category 483 Citations Meetings Minutes: Votes for, against, abstention and reason not recorded;
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Human Research Protection Program 101 March 19, 2007 Cincinnati, OH.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
 Understanding the IRB Process University of Tennessee Health Science Center Institutional Review Board.
Preparing the IRB and Investigators for an External Audit/Site Visit
Sara Brand Associate Director Research Compliance Administration.
OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP May 2, 2015.
CHILD ASSENT IRB Member Continuing Education. AAHRRP Element 1I.4. B. The IRB or EC has and follows written policies and procedures requiring appropriate.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Experience and innovation in ethical review. ® An Update and Overview of the US Common Rule Regulations David Borasky, MPH, CIP Copernicus Group IRB CAREB.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
PwC Protecting the People who Volunteer to Participate in Research.
CCAS Annual Conference: New Orleans, LA November 11, 2010 The Role of Deans: Regulatory & Administrative Responsibilities Michelle Feige, MSW Public Health.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
The Basics of Human Research Protections Office of Research Oversight (ORO) Veterans Health Administration Department of Veterans Affairs February 27,
WELCOME to the TULANE UNIVERSITY HUMAN RESEARCH PROTECTION OFFICE WORKSHOP for SOCIAL/BEHAVIORAL RESEARCH (March 2, 2010) Tulane University HRPO Uptown.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
OHRP Compliance Oversight Procedures Compliance Process OHRP discovers or receives an allegation or indication of non-compliance COMPLAINT(S) – PI, IRB.
Protecting Human Subjects in Research A Primer on Understanding the Scope, Purpose, and Process of the Kaplan University IRB Prepared by the Office of.
Non-compliance with Human Subjects Research Regulations J. Bruce Smith, MD, CIP November 2014 Continuing Education for IRB Members.
1 Research & Development Committee Brenda Cuccherini, Ph.D., MPH Office of Research & Development January 2007.
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
PRIMER: Human Subjects, Past, Present, and Future Susan Metosky, Arizona State University Debra Murphy, Arizona State University.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Protecting Human Subjects Overview of the Issues Applications to Educational Research The IRB Process.
OHRP Update Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research Protections 3 rd Annual Medical Research Summit.
Conditional IRB Approval
Reportable Events & Other IRB Updates February 2017
Investigator Responsibilities in Human Subjects Research
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
Updates to Expedited Review Procedures
This takes approximately 5 minutes or less from start to finish
Jeffrey M. Cohen, Ph.D. Associate Dean,
HHS Reporting Requirements and Adverse Events
Event Reporting in Human Subjects Research
The Second Annual Medical Research Summit
Presentation transcript:

OHRP’s Compliance Oversight Procedures Kristina C. Borror, Ph.D. Division of Compliance Oversight Office for Human Research Protections

Presentation Overview OHRP compliance oversight activities Common areas of noncompliance identified by OHRP Underlying causes of noncompliance Solutions to correct/prevent noncompliance

OHRP’s Jurisdiction Research conducted or supported by HHS Research conducted at an institution holding an applicable Assurance of Compliance

OHRP Compliance Oversight Activities

Compliance Oversight Investigation Receive allegation of noncompliance Determine OHRP jurisdiction Written inquiry to appropriate institutional officials Review of institution report and relevant IRB documents Additional correspondence/telephone interviews/site visit as needed Issue final determinations

For-Cause Site Visits When does OHRP conduct a site visit? Based on: nature and severity of the allegations evidence of systemic problems appropriateness of any corrective actions taken perceived need for more in-depth discussions with institution staff

For-Cause Site Visits Interviews with-- institutional administrator(s) IRB Chairperson(s) IRB members IRB staff investigators who conduct human subjects research others as appropriate

For-Cause Site Visits Record Reviews OHRP selects 50-75 active protocols for review of entire IRB record on-site last 25 protocols approved by the IRB under an expedited review procedures last 25 amendments approved by the IRB under an expedited review procedure Protocols determined to be exempt during the past 6 months minutes for all IRB meetings for last 4 years

For-Cause Site Visits Findings Meet with the signatory officials on the Assurance, or their designees on last day to describe OHRP’s findings

Compliance Oversight Investigation Possible Determinations/Outcomes (1) Protections under an institution’s Assurance are in compliance Protections under an institution’s Assurance are in compliance, but recommended improvements have been identified Noncompliance identified, and corrective actions required Noncompliance identified, and Assurance restricted pending required corrective actions

Compliance Oversight Investigation Possible Determinations/Outcomes (2) Noncompliance identified, and OHRP approval of Assurance withdrawn OHRP may recommend to appropriate HHS Officials or PHS agency heads that: an institution or investigator be temporarily suspended or permanently removed from participation in specific project peer review groups be notified of an institution’s or an investigator’s past noncompliance prior to review of new projects

Compliance Oversight Investigation Possible Determinations/Outcomes (3) OHRP may recommend that institutions or investigators be declared ineligible to participate in HHS-supported research (Debarment). Debarment will be initiated in accordance with procedures specified at 45 CFR Part 76.

Common Areas of Noncompliance Identified by OHRP

Common Areas of Noncompliance (1) OHRP Compliance Activities: Common Findings and Guidance - 7/10/02 http://ohrp.osophs.dhhs.gov/references/findings.pdf Borror et al, “A Review of OHRP Compliance Oversight Letters.” IRB: Ethics and Human Research. Sept-Oct 2003; Vol 25 No 5: 1-4.

Common Areas of Noncompliance (2) Initial and continuing IRB review Expedited IRB review procedures Reporting of unanticipated problems IRB review of protocol changes Informed consent IRB membership, expertise, staff, support, and workload Documentation of IRB procedures, activities, and findings

Common OHRP Findings Initial and Continuing IRB Review Insufficient information to make determinations required under 45 CFR 46.111 Inadequate review at convened meetings No substantive continuing review Failure to conduct continuing review at least annually Lack of quorum at convened meetings Research conducted without IRB review

Common OHRP Findings Expedited Review Inappropriate use of expedited review for initial and continuing review Inappropriate use of expedited review for protocol modifications Failure to advise full IRB of expedited approvals

Common OHRP Findings Informed Consent Failure to include all required elements of informed consent [45 CFR 46.116(a)] Failure to include additional elements of informed consent when appropriate [45 CFR 46.116(b)] Underestimation of risks/overestimation of potential benefits Language too complex Exculpatory language

Common OHRP Findings IRB Membership, Expertise, Support Lack of diversity of IRB membership Lack of IRB expertise regarding research with children Lack of prisoner/prisoner representative on IRB for review of research with prisoners IRB Chair/members lack sufficient understanding of HHS regulations Inadequate resources

Common OHRP Finding IRB Policies, Procedures and Findings (1) Inadequate IRB records Inadequate IRB minutes Failure of IRB to consider additional safeguards for vulnerable subjects Failure of IRB to make required findings when reviewing research involving children

Common OHRP Finding IRB Policies, Procedures and Findings (2) Failure of IRB to make and document required findings for waiver of informed consent Failure to make required findings for IRB waiver of a signed informed consent document Lack of appropriate written IRB policies and procedures

Underlying Causes of Noncompliance

Underlying Causes of Noncompliance Inadequate education of IRB members, IRB staff, and investigators Inadequate staff and resources for the IRB Overburdened IRBs

Solutions to Correct/Prevent Noncompliance Education Adequate IRB staff and resources Adequate number of IRBs Adequate IRB documentation (in particular, adequate minutes of IRB meetings) Periodic self-assessment of institutional system for protecting human subjects